Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecular switch found that allows cancer cells to become mobile

28.09.2004


Researchers at The University of Texas M. D. Anderson Cancer Center have figured out a key molecular step by which a cancer cell can unhook itself from the mesh weave of other cancer cells in a tumor, and move away to a different part of the body - the process, known as metastasis, that makes cancer so dangerous.



Describing what they call a critical "molecular switch" - detailed in the advance online edition of the journal Nature Cell Biology - the researchers say the door is now open to designing new ways to block that metastasis. "It always has been a mystery as to what allows a cancer cell to become mobile and move away from a tumor, but now we have found a very interesting mechanism that explains it," says the study’s lead author, Mien-Chie Hung, Ph.D., a professor and chair of the Department of Molecular and Cellular Oncology. That switch, in the form of an enzyme known as GSK-3ß, which is known to alter the function of proteins, may "offer us an anticancer strategy to pursue," Hung says.

Most cancers are of the "solid tumor" variety, and are made up of epithelial cells - those which make up the membranous tissue covering organs and other internal surfaces of the body. Although epithelial cells are firmly fixed to each other in a network that makes up tissue, researchers know from the study of developmental biology that embryonic epithelial cells have the ability to move. To do that, epithelial cells take on the characteristics of what are known as "mesenchymal" cells, those that develop into connective tissue and blood vessel cells, among other tissue types. They are capable of forming collagen fibers that allows them to "creep along" to where they are needed during development.


This process, known as "epithelial-mesenchymal transition (EMT)," has recently been observed in cancer progression, Hung says. "It was discovered that the increased motility and invasiveness of cancer cells resembles the EMT that occurs during embryonic development," he says. "And since about 90 percent of cancer deaths result from local invasion and distant metastasis of tumor cells, an insight into how this process works in cancer has been urgently needed."

Some of this transition process in cancer cells already has been described, Hung says. What has been known is that epithelial cells have a lot of protein known as E-cadherin, which act like anchors, fixing the cells onto the tissue membrane while gluing cells to each other. In contrast, mesenchymal cells do not "express" E-cadherin, which allows them to move freely.

Another piece of the puzzle was already in place: a transcription factor known as "snail" was found to control the gene that produces the E-cadherin protein. Snail turns off E-cadherin expression, thus freeing epithelial cell from its tethers. So the question Hung and his research team explored is: what regulates snail? What "tells" snail to turn off E-cadherin? "Cells without E-cadherin are not stuck to each other any more and can move, so we looked for the regulator of snail," Hung says.

Through a series of experiments, they found that the GSK-3ß enzyme controls snail. It does this by directing snail out of the cell’s nucleus (where proteins are located) and into the cell’s cytoplasm, where it is then degraded. "This enzyme tells the snail transcription factor to go to the wrong place, where it is then destroyed," Hung says.

So when GSK-3ß controls the action of snail, a cancer cell continues to produce E-cadherin and retains all the properties of a fixed epithelial cell, the researchers discovered. Tumor cells in which GSK-3ß activity is repressed become unanchored, Hung says, suggesting that a therapy that bolsters GSK-3ß may repress the ability of cancer to spread.

Hung and his group also say that known cancer pathways, such as those that involve the epidermal growth factor receptor (EGFR) have been shown to inhibit the GSK-3ß enzyme. "So this all makes sense. We have mechanistically shown how a signaling pathway known to promote cancer development can also promote metastasis," he says. "Now we have to work on ways to inhibit that process."

Nancy Jensen | EurekAlert!
Further information:
http://www.mdanderson.org

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>